U.S. Trade Distributors Stock News

On 26 February 2026, PTC Inc. released a fully cloud-native Model-Based Definition capability within its Onshape CAD and PDM platform, enabling engineers to embed manufacturing information directly into always up-to-date 3D models. This move positions Onshape as a more integrated, browser-accessible hub for product data, potentially simplifying collaboration across design, manufacturing, and quality teams. We’ll now examine how embedding manufacturing data directly into cloud-native 3D...

Ionis Pharmaceuticals overview and recent share performance Ionis Pharmaceuticals (IONS) has drawn investor attention recently, with the share price closing at US$80.60 and showing mixed returns over the past week, month, past 3 months, and year to date. Over the past year, total return is 157.10%. The past 3 years and 5 years show total returns of 125.08% and 57.21% respectively, providing context for how the stock has behaved across different holding periods. See our latest analysis for...

Magnite (MGNI) closed out FY 2025 with Q4 revenue of US$205.4 million and basic EPS of US$0.86, capped by trailing 12 month EPS of US$1.01 that sits on trailing 12 month revenue of US$714.0 million. Over the past six quarters in this dataset, revenue has moved from US$162.0 million in Q3 2024 to US$205.4 million in Q4 2025, while quarterly EPS shifted from US$0.04 to US$0.86, creating a backdrop where margins have become a central focus for investors assessing the latest print. See our full...

Earlier in 2026, Futu Holdings announced that it would report its fourth-quarter and full-year 2025 results on March 12, 2026, before U.S. markets open, accompanied by a management earnings call and webcast. Alongside its earnings timetable, Futu’s moomoo platform has been promoting financial education through initiatives like the Student Stock Showdown, underscoring how its brokerage technology is also being used to build investing literacy among younger users. With stronger recent earnings...

In February 2026, Watsco, Inc. reported that its fourth-quarter 2025 sales fell to US$1,578.76 million and net income to US$71.75 million, and also approved a 10% increase in its annual dividend to US$13.20 per share for both Common and Class B shares. The combination of softer recent earnings and a higher dividend, underpinned by management’s emphasis on improved gross margins and a debt-free balance sheet, highlights how Watsco is prioritizing shareholder returns while contending with...

Definium Therapeutics, Inc. reported full-year 2025 results on February 26, 2026, posting a wider net loss of US$183.79 million and basic and diluted loss per share from continuing operations of US$2.06, compared with US$108.68 million and US$1.54 a year earlier. This larger loss, alongside management’s recent participation in multiple healthcare investor conferences, highlights how the company is balancing capital-intensive late-stage clinical development with efforts to keep investors...

If you are looking at Credicorp and wondering whether the current share price still reflects solid value, you are not alone. This article will walk through what the numbers actually say. The stock last closed at US$355.48, with returns of 1.7% over 7 days, a marginal 0.2% decline over 30 days, 24.1% year to date, 106.7% over 1 year and 183.7% over 5 years. This naturally raises questions about how much future upside or risk is already built in. Recent news coverage has focused on Credicorp's...

Arlo Technologies (ARLO) has drawn fresh attention after recent trading left the stock up 3.6% over the past week, but down over the past month and past 3 months, prompting closer scrutiny from investors. See our latest analysis for Arlo Technologies. That recent 6.2% 7 day share price return comes after weaker momentum earlier in the year, with a 30 day share price return of 6.52% and year to date share price return of 6.73%. The 3 year total shareholder return is roughly 3.3x, which hints...

Paylocity Holding (PCTY) is in focus after second quarter results came in ahead of guidance, prompting higher revenue projections for fiscal 2026 and an updated outlook for total and recurring revenues. See our latest analysis for Paylocity Holding. The second quarter beat and upgraded fiscal 2026 revenue outlook arrive after a mixed share price run, with an 8.52% 1 day share price return and 6.59% 7 day share price return contrasting with a 19.95% 30 day share price decline and a 44.87% 1...

Earlier in February 2026, YETI Holdings appointed former Home Depot finance executive Scott Bomar as its new Chief Financial Officer, reported fourth-quarter and full-year 2025 results showing higher quarterly sales and earnings, issued 2026 sales growth guidance of 6% to 8%, and completed a US$497.72 million share repurchase program. These announcements highlight YETI’s focus on leadership refresh, disciplined capital returns through buybacks, and continued investment in product innovation...

If you are wondering whether Arch Capital Group at around US$99.65 is offering good value right now, you are not alone. The stock has returned 1.3% over the last 7 days, 6.6% over the past 30 days, 6.2% year to date, 8.2% over 1 year, 47.8% over 3 years, and 193.5% over 5 years. These figures may shape how investors think about its current risk and reward trade off. Recent news coverage around Arch Capital Group has focused on its positioning within the insurance sector and its broader role...

CECO Environmental (NasdaqGS:CECO) announced a proposed US$2.2b merger with Thermon to form a combined industrial environmental and thermal solutions company. The boards of both companies have unanimously approved the transaction, which includes plans for changes to the combined company’s board composition. The deal targets cost synergies and a broader offering in areas such as industrial process efficiency, energy transition and decarbonization. Law firms and shareholder rights groups have...

Balchem Corporation recently reported fourth-quarter 2025 sales of US$263.62 million and net income of US$39.23 million, with full-year 2025 sales of US$1.04 billion and net income of US$154.85 million, all higher than the prior year. The company also delivered higher diluted earnings per share from continuing operations for both the quarter and the full year, pointing to improved profitability alongside revenue growth. We will now examine how this earnings improvement, particularly the rise...

Recent commentary around Power Integrations (POWI) has focused on its institutional backing and its emphasis on energy efficient power solutions. Together, these factors appear to be reshaping how the market views the company’s earlier operational challenges. See our latest analysis for Power Integrations. The recent move above longer term trading levels has come with a 44.23% 90 day share price return and a 29.92% year to date share price return. However, the 1 year total shareholder return...

Copa Holdings (CPA) is back in focus after a flurry of analyst opinions and the filing of its latest annual report, which gives investors fresh information on operations, finances, and overall network performance. See our latest analysis for Copa Holdings. At a share price of $148.03, Copa’s recent 90 day share price return of 21.54% and 30 day share price return of 7.88% point to building momentum. The 1 year total shareholder return of 71.45% underlines how strongly the stock has rewarded...

Kinder Morgan (KMI) has drawn fresh attention after reporting its highest ever Q4 and full year net incomes, supported by record Natural Gas Pipelines performance, a larger project backlog, and increased investor outreach. See our latest analysis for Kinder Morgan. Recent Q4 results and a larger project backlog appear to be feeding into sentiment, with a 30 day share price return of 11.73% and a 1 year total shareholder return of 31.57%. The 3 and 5 year total shareholder returns above 100%...

Rhythm Pharmaceuticals (RYTM) has wrapped up FY 2025 with Q4 revenue of US$57.3 million and a basic EPS loss of US$0.73, while trailing 12 month figures show total revenue of US$189.8 million and a basic EPS loss of US$3.11. Over recent quarters, the company has seen revenue move from US$41.8 million in Q4 2024 to US$57.3 million in Q4 2025, with basic EPS losses ranging between US$0.72 and US$0.82 per quarter. This sets up a story where revenue is building but margins remain under...

Uniti Group: Recent Performance Context Uniti Group (UNIT) has caught investor attention after a mixed stretch in its share performance, with a month gain of 2.5% and a past 3 months return of 17.6% contrasting with a 1 year total return decline of 20.8%. At a last close of US$7.49, the stock also sits against a longer track record that includes a 3 year total return of 8.8% and a 5 year total return decline of 41.9%, giving investors several time frames to compare. See our latest analysis...

Recent moves in Bunge Global (BG) have been driven by a wave of upbeat analyst commentary following its fiscal Q4 earnings beat and conservative guidance. This has put fresh attention on the agribusiness group’s fundamentals. See our latest analysis for Bunge Global. The recent cluster of upbeat analyst views has come after a strong run in the shares, with a 24.31% 90 day share price return and 28.91% year to date share price return, while the 1 year total shareholder return of 68.06%...

In recent trading, Freedom Holding Corp reported that insurance premium income fell after regulators capped commissions on policies tied to bank and microfinance loans, while its brokerage customer base reached 828,000 and banking customers grew to 4.5 million as of December 31. This combination of regulatory pressure on a fee-generating line and simultaneous expansion in core brokerage and banking relationships highlights a shift in how Freedom Holding may be balancing revenue...

In February 2026, Jackson Financial Inc. reported fourth-quarter 2025 revenue of US$1,988 million but swung to a net loss of US$204 million, while also increasing its common dividend, declaring a preferred dividend, and completing a large share repurchase program that retired just over 40% of its shares since 2021. Despite record retail annuity sales and continued capital returns, the sharp drop in yearly net income to US$27 million and a move from earnings per share to a loss per share have...

Newmark Group (NMRK) has drawn investor interest after recent share moves, with the stock showing mixed returns over the past week, month, and past 3 months, while longer term performance has differed. See our latest analysis for Newmark Group. At a share price of US$14.89, Newmark Group has seen a 1 day share price return of 1.64%. Its 30 day and 90 day share price returns of 13.33% and 14.33% respectively point to fading short term momentum, despite a 3 year total shareholder return of...

Ultragenyx Pharmaceutical (NasdaqGS:RARE) announced that the US FDA has accepted its Biologics License Application for DTX401, a gene therapy for Glycogen Storage Disease Type Ia. The FDA has granted Priority Review to the application, signaling an expedited assessment timeline. If approved, DTX401 could become the first pharmacologic treatment option for people living with Glycogen Storage Disease Type Ia. For Ultragenyx, with a current share price of $23.04, this regulatory milestone...

Corning (GLW) is back in focus after its share price jumped on growing demand for AI data center fiber and a multiyear Meta Platforms agreement that could reach US$6b in value. See our latest analysis for Corning. The recent Meta agreement and rising AI data center interest sit alongside sharp stock moves, with a 36.96% 1 month share price return and a 78.50% 3 month share price return contributing to a very large 1 year total shareholder return. If Corning’s AI infrastructure story has...